Runben Biotechnology Co (SHSE:603193) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Runben Biotechnology Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Runben Biotechnology Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Runben Biotechnology Co's long-term debt to total assets ratio declined from Sep. 2023 (0.00) to Sep. 2024 (0.00). It may suggest that Runben Biotechnology Co is progressively becoming less dependent on debt to grow their business.

Runben Biotechnology Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Runben Biotechnology Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Runben Biotechnology Co LT-Debt-to-Total-Asset Chart

Runben Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

0.01

Runben Biotechnology Co Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial								-	-	-	-	-

Runben Biotechnology Co LT-Debt-to-Total-Asset Calculation

Runben Biotechnology Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	2.042	/	2018.871
	=	0.00

Runben Biotechnology Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	1.763	/	2218.432
	=	0.00

Runben Biotechnology Co (SHSE:603193) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Runben Biotechnology Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Runben Biotechnology Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Runben Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Runben Biotechnology Co Ltd (SHSE:603193) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangdong, Guangzhou, CHN, 510627

Website

https://www.runben.com

Runben Biotechnology Co Ltd is engaged in research & development, production and sales of mosquito repellent and personal care products.

Runben Biotechnology Co Headlines

No Headlines